94P Patient quality of life (QoL) from the GeparX trial on the addition of denosumab (Dmab) added to two different nab-paclitaxel (nP) regimens as neoadjuvant chemotherapy (NACT) in primary breast cancer (BC)

Authors :: M. Reinisch
J-U. Blohmer
T. Link
M. Just
M. Untch
O. Stötzer
P.A. Fasching
A. Schneeweiss
P. Wimberger
S. Seiler
J. Huober
M. Thill
C. Jackisch
K. Rhiem
C. Solbach
C. Hanusch
C. Denkert
K. Engels
V. Nekljudova
S. Loibl
Source :: Annals of Oncology. 33:S166-S167
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Tools